The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
Conexeu Sciences is aiming CXU™ at the largest unclaimed frontier in injectable aesthetics: restoring body fullness at a scale today's fillers were never built to reach. The move builds on the…
Read the full articleYou might also wanna read
Inditex estrena etiquetado accesible para facilitar la compra a las personas con discapacidad visual
La implantación del proceso aumentará de forma paulatina y terminará la próxima temporada de primavera/verano de 2027
IBRAMED completa 32 anos em setor de saúde em alta
A indústria brasileira de dispositivos médicos segue em expansão. De acordo com dados da Associação Brasileira da Indústria de Dispositivos
Une révolution ? Ce gel injectable pourrait non seulement soigner l’arthrose mais aussi permettre aux médecins de suivre le traitement en direct
Un hydrogel innovant à base d'acide hyaluronique pourrait révolutionner le traitement de l'arthrose en freinant la dégradation articulaire e
Navigating the Gray Area: The Unregulated Surge of Unique GLP-1 and GLP-1/GIP Products
Purpose: To identify unique compounded semaglutide and tirzepatide products that existed after the shortage grace period ended and to assess
GC Cell Wellbeing Targets Japan's Aesthetic Market with ECM Skin Booster 'Ribonne'
GC Cell Wellbeing targets Japan's medical aesthetic market with its ECM skin booster Ribonne, introducing it alongside PDRN products at the
L'action Nanobiotix s'envole de plus de 5 %, sur le podium du SBF 120
La biotech française signe une nouvelle envolée en cette matinée de vendredi, portée par un relèvement d'objectif de cours d'un bureau d'ana
Comments
Sign in to join the conversation.
No comments yet. Be the first.